Edwards Lifesciences reported $917.9M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abiomed ABMD:US USD 134.06M 6.7M
Atricure ATRC:US USD 57.6M 1.28M
Baxter International BAX:US USD 3.71B 208M
Becton, Dickinson and BDX:US USD 7.81B 731M
Cardiovascular Systems CSII:US USD 37.16M 2.8M
Cooper Companies COO:US USD 1.28B 95.5M
Cryolife CRY:US USD 45.99M 4.35M
Dexcom DXCM:US USD 900.5M 93.5M
Edwards Lifesciences EW:US USD 917.9M 51.2M
Globus Medical GMED:US USD 145.26M 762K
Hologic HOLX:US USD 937.7M 63.2M
Icu Medical ICUI:US USD 489.03M 3.05M
Inogen INGN:US USD 65.74M 6.4M
Insulet PODD:US USD 334.2M 54.9M
Intuitive Surgical ISRG:US USD 1.69B 511.8M
Masimo MASI:US USD 587.3M 35.3M
Medtronic MDT:US USD 14.47B 416M
Merit Medical Systems MMSI:US USD 213.04M 17.44M
Nuvasive NUVA:US USD 697.4M 3.95M
Stryker SYK:US USD 4.57B 167M
Tandem Diabetes Care TNDM:US USD 173.63M 34.37M
Teleflex TFX:US USD 610.94M 497K
Zimmer Biomet Holdings Inc ZBH:US USD 2.3B 167.9M